Anyone who has watched Channel 4s hit series One Born Every Minute will tell you that seeing new life come into the world can be pretty magical.
Carolyn Sayle and her daughters Neenah and Shauni Higgins can wholeheartedly attest to that.
Although they have been present at countless births , they are not midwives. They have an altogether different role but one that could potentially save someones life.
All three work for the charity Anthony Nolan as dedicated cord blood collectors.
Their job involves asking expectant mums to donate their umbilical cord blood which would usually be thrown away for use in stem cell transplants.
Such transplants are often used when a patient doesnt have a match from an adult donor, such as if the patient is from an ethnic minority background, because the young cells are more adaptable to different genetic types.
Shauni says: Donating cord blood can make the difference between life and death for somebody who is suffering from blood cancer or leukaemia and its risk-free for the mother and baby .
Carolyn, 55, was the first to start working for the charity in March 2014 after relocating from Manchester, where she was an IVF coordinator, to Saxmundham, Suffolk, to live with her partner Paul, 60.
She says: Id known about Anthony Nolan for years, having joined the register as a bone marrow donor during one of its first big recruitment drives in the 70s.
Its a really important job that we do, and it still fascinates me that something we would otherwise throw away could save someones life.
Carolyn, who is based at Kings College Hospital in London, says collection is the easiest part of the job. So far she has done 455.
Its the bit that comes before thats difficult, she says. The majority of expectant mothers dont even know they can donate their placentas and umbilical cord.
Most are already in labour so theyre not in the best frame of mind when we approach them. Youve got to have people skills and know when not to go in the look on their face will tell you.
Carolyn says she starts every shift never knowing what will happen.
Weve got ladies walking in constantly in all stages of labour, she says. We try to speak to them as they come in as well as keeping track of deliveries.
"It can be a bit hectic when youve got a few ladies pushing and you dont know which one youll collect from first.
Once a woman has consented, a cord collector will be there in the delivery room or in theatre if they are having a caesarean section.
After delivery, the cord and placenta are taken into a separate room. The collector has to massage the placenta and the blood drains through the cord into a collection bag before it is cryogenically frozen.
One of Carolyns cord collections was used in a transplant last year. She recalls: I thought, How fantastic is that? I was so proud and told Neenah and Shauni straight away.
Video Unavailable
Click to play Tap to play
Play now
Watch this video again
Video will play in
Staff arent told where a donation is issued in order to maintain confidentiality, but Anthony Nolan can track how patients are doing further down the line.
Carolyn says: Its early days with it only being last year so I havent heard anything yet.
Shauni, 23, was so impressed with her mums work she became a cord collector herself at St Marys Hospital, Manchester, last May.
Shauni, who lives in Bagley, Manchester, with partner Jordan, 28, explains: Id loved the few placements Id done working in hospitals, and quickly realised I found my dream job when I joined Anthony Nolan.
On my first day I went into theatre to see a c-section. It was amazing and the first time Ive ever seen a birth. Nothing prepares you.
She says one of the most difficult parts of the job is when women decide not to donate. It seems such a shame for something so valuable to go to waste, she says.
Nearly all the cords we collect get used for something those that arent clinical-grade are used in research.
Mum-of-one Neenah, 28, started working alongside her sister as a cord collector at St Marys last July after deciding on a career change after working as an Estee Lauder manager and make-up artist.
She donated her own cord blood when she gave birth to Penelope, 20 months, and says: Id heard so much about donating from mum and I wanted to give something back. I wanted to do something that helped people.
Neenah, who lives in Urmston, Greater Manchester, with fianc Ian, 30, now wears scrubs and no make-up to work. She says: A lot of the time I get blood on my face so I dont want to be worrying about smudging my foundation when I wipe it off.
But being on a maternity unit can be an emotional roller coaster.
She says: I had a lady who had been induced but she had a placentalabruption and was rushed into theatre for an emergency c-section. She lost a lot of blood so I couldnt do the collection and the baby was very poorly.
That was horrible. It does affect you because you build up a relationship with people. You can sometimes come home after a shift and have a cry.
Working together has brought about a bit of family rivalry.
Neenah says: Last week Shauni was saying shed extracted 235ml of blood and I said, Well, I got 240ml.
Shauni adds: We have a bit of a competition when it comes to the size of the collections. She beat me by five. I always beat mum though!
Donating cord blood is completely risk-free for mother and baby, and doesnt interfere with your birth plan.
Anthony Nolan can currently collect cord blood in four hospitals St Marys, Manchester; Kings College Hospital, London; Leicester Royal Infirmary and Leicester General Hospital.
You can only donate if youre giving birth at one of these hospitals and you cannot donate if you are having a home birth.
You can register your interest online before birth at anthonynolan.org .
Each mum who donates is given a baby bundle, which includes a certificate and babygro, as a thank you.
There is no subsequent contact between cord donors and recipients who then benefit.
The NHS cord blood bank collects in a further six hospitals Barnet General Hospital, Luton and Dunstable Hospital, Watford General Hospital, and Londons Northwick Park, St Georges and University College Hospitals.
Read the original here:
How new mums' umbilical cord blood can save lives as 'collectors' use it for stem cell transplants - Mirror.co.uk
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021